New quinolone/steroid combination for topical treatment of acute otitis: early- and late-phase study results.
Conroy
Peter J
PJ
Alcon Laboratories, Fort Worth, Texas, USA.
D000287:Administration, Topical; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002939:Ciprofloxacin / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003907:Dexamethasone / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D007223:Infant; D010031:Otitis / Q000188:drug therapy*; D013997:Time Factors
D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D002939:Ciprofloxacin; D003907:Dexamethasone